Abstract:Xudong Che, Baixue Wu, Hongxia Zhang, Dengzhi Jiang, Wenqiao Fu, Zhaohui He Department of Neurosurgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China Correspondence: Zhaohui He, Email Background: Hemoglobin decrement is a common complication after aneurysmal subarachnoid hemorrhage (aSAH) and is associated with poor outcome. However, the mediating variables on the causal pathway between hemoglobin decrement and poor outcome in aSAH are not clear. Methods: This is a single-center retrospective observational study containing all consecutive patients with aSAH admitted to our hospital between January 1, 2019, and June 30, 2022. Hemoglobin decrement was defined as the hemoglobin at admission minus the minimum hemoglobin during hospitalization. Calculation of cutoff value using ROC curve Youden index. The main exposure of interest was a hemoglobin decrement greater than the cutoff value. The primary outcome was poor outcome at 3 months (mRS 4– 6). Results: A total of 480 patients with aSAH were included in the study, 414 (71.1%) had a favorable and 66 (28.9%) had a poor outcome at 3 months. The cut-off value for calculating the degree of hemoglobin decrease using the ROC curve was 12.5 g/l. Hemoglobin decrement greater than the cutoff value was significantly associated with pneumonia (OR 3.12; 95% CI 1.78– 5.57; p < 0.001), cerebral infarction (OR 3.06; 95% CI 1.80– 5.30; p < 0.001), and poor prognosis (OR 2.88; 95% CI 1.44– 5.92; p = 0.003) at 3 months. The mediation effect was significant for both pneumonia and cerebral infarction, with the average causal mediation effect (ACME) were 0.04 (95% CI 0.02– 0.08; p < 0.05) and 0.05 (95% CI 0.02– 0.08; p < 0.001), respectively. Conclusion: Hemoglobin decrement during hospitalization was significantly associated with poor prognosis after aSAH, and the increased risk of cerebral infarction and pneumonia might mediate this effect. Avoiding hemoglobin decrement greater than 12.5g/l may improve the prognosis of patients with aSAH. Keywords: aneurysmal subarachnoid hemorrhage, hemoglobin decrement, cerebral infarction, pneumonia Aneurysmal subarachnoid hemorrhage (aSAH) is a serious cerebrovascular accident that kills more than 30% of patients and leaves neurological deficits in approximately 25% of survivors. 1 Anemia is a common complication after SAH, and studies have reported that about half of patients may develop anemia during hospitalization. 2 In addition, patients with post-SAH anemia are more likely to have delayed cerebral ischemia (DCI) and a poor outcome. 3–6 Previous studies have reported that lower mean hemoglobin during the acute phase of aSAH is a predictor of vasospasm and poor neurological prognosis at discharge. 7 However, studies on whether to transfuse blood to correct anemia after aSAH are now at an impasse. 8 A small RCT on the feasibility of correcting anemia after aSAH showed that blood transfusion did not significantly reduce the incidence of cerebral infarction. 9 Recently, Asghar et al reported that in patients with SAH, independently of any hemoglobin values, greater hemoglobin decrement during hospitalization was associated with DCI and poor prognosis. 10 Therefore, we speculate that the factor contributing to the poor prognosis of SAH may be the process of hemoglobin decrement, rather than anemia caused by a drop in hemoglobin. In addition, pneumonia, a common extracranial complication after aSAH, affects the prognosis of aSAH and is prevalent in anemic patients as well. 11–13 However, few studies have reported a correlation between pneumonia, anemia, and aSAH. Traditional causal analysis is a blind box effect, we know that decreased hemoglobin may affect the prognosis of aSAH, but we do not know how this effect occurs. Causal mediation analysis can effectively overcome this shortcoming by identifying intermediate variables (or mediators) that exist in the causal pathway between cause and effect. 14,15 In this study, we sought to explore the association between minimum hemoglobin and hemoglobin decrement with poor prognosis in SAH, as well as, using mediation analyses, to explore the mediating factors by which hemoglobin decrement jeopardizes the prognosis of SAH. This is a single-center retrospective observational study containing all consecutive patients with aSAH admitted to our hospital between January 1, 2019, and June 30, 2022. Exclusion criteria included traumatic SAH, non-aneurysmal SAH, onset of more than 72 hours, death or discharge within 72 hours of onset, conservative treatment of aneurysms, missing data, and loss to follow-up. This study was approved by the Ethics Committee of the hospi -Abstract Truncated-

Letter to the editor: "Association of hemoglobin drift and outcomes in patients with aneurysmal subarachnoid hemorrhage"

Association between baseline hemoglobin level and early neurological deterioration after intravenous thrombolysis in patients with acute ischemic stroke.

Hematocrit drift and outcomes in surgical patients with aneurysmal subarachnoid hemorrhage

Red blood cell transfusion in patients with subarachnoid hemorrhage: a multidisciplinary North American survey

Effect of Peri-operative Blood Transfusion on Neurological Outcome Following Aneurysmal Subarachnoid Hemorrhage: A Prospective Observational Study

Comment on: "Decreased timing to vasospasm prophylaxis improves outcomes among patients with aneurysmal subarachnoid hemorrhage (aSAH) on prehospital CCBs, ARBs, or ACE-inhibitors"

Haptoglobin Treatment for Aneurysmal Subarachnoid Hemorrhage: Review and Expert Consensus on Clinical Translation

Higher hemoglobin is associated with less cerebral infarction, poor outcome, and death after subarachnoid hemorrhage

Anemia and Red Blood Cell Transfusion in Aneurysmal Subarachnoid Hemorrhage

Anemia After Aneurysmal Subarachnoid Hemorrhage Is Associated With Poor Outcome and Death

The Effects of Red Blood Cell Transfusion on Functional Outcome after Aneurysmal Subarachnoid Hemorrhage

Letter to the editor: "Beyond nimodipine: advanced neuroprotection strategies for aneurysmal subarachnoid hemorrhage vasospasm and delayed cerebral ischemia"

Association of Postoperative Drift in Hemoglobin With Mortality After Brain Tumor Craniotomy

Impact of anemia on acute ischemic stroke outcomes: A systematic review of the literature

Impact of perioperative hemoglobin-related parameters on clinical outcomes in patients with spinal metastases: identifying key markers for blood management

Emerging Treatments for Subarachnoid Hemorrhage

Association of Hemoglobin Decrement During Hospitalization with Prognosis of Aneurysmal Subarachnoid Hemorrhage and Mediation Effects of Cerebral Infarction and Pneumonia

Predictive Value of Hematologic Inflammatory Markers in Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage

Letter to Editor, "Giant unruptured middle cerebral artery aneurysm revealed by intracranial hypertension: is a systematic decompressive hemicraniotomy mandatory?

Association between blood pressure control during aneurysm clipping and functional outcomes in patients with aneurysmal subarachnoid hemorrhage

What Factors Determine Treatment Outcome in Aneurysmal Subarachnoid Hemorrhage in the Modern Era? A Post Hoc STASH Analysis